Cha Albert
Insider CIK 1397906 · DNAI Director · CBYL Director · CAPN 10% owner · ACRS Director · MNLO Director · BHVN Director · FLSC Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FLSC Frazier Life Sciences Acqu | P Buy | 2026-10-15 | 2026-10-15 | 300,000 | $10.00 | $3.00M | 300,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-09-26 | 2023-09-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-09-11 | 2023-09-13 | 12,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-09-11 | 2023-09-13 | 6,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-09-11 | 2023-09-13 | 12,000 | $7.88 | $94.6K | 18,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-09-11 | 2023-09-13 | 18,000 | $10.50 | $189.0K | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-09-11 | 2023-09-13 | 6,000 | $6.71 | $40.3K | 6,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-10-13 | 2022-10-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-09-30 | 2021-10-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2020-10-30 | 2020-11-03 | 68,255 | $17.17 | $1.17M | 1,090,748 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2020-10-30 | 2020-11-03 | 47,431 | $17.34 | $822.5K | 1,138,179 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-10-01 | 2020-10-02 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-10-02 | 2019-10-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-29 | 2019-07-30 | 5,137 | $17.13 | $88.0K | 124,566 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-29 | 2019-07-30 | 24,730 | $17.13 | $423.6K | 1,022,493 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-26 | 2019-07-30 | 21,942 | $16.83 | $369.3K | 997,763 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-26 | 2019-07-30 | 4,558 | $16.83 | $76.7K | 119,429 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-19 | 2019-07-19 | 10,320 | $17.68 | $182.5K | 114,871 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-19 | 2019-07-19 | 49,680 | $17.84 | $886.3K | 975,821 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-17 | 2019-07-19 | 220 | $16.93 | $3.7K | 104,551 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2019-07-17 | 2019-07-19 | 1,060 | $16.97 | $18.0K | 926,141 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-10-03 | 2018-10-05 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | P Buy | 2018-09-10 | 2018-09-12 | 1,058,824 | $17.00 | $18.00M | 1,359,149 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2018-05-01 | 2018-05-03 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award | 2018-03-14 | 2018-03-15 | 72,727 | $27.50 | $2.00M | 2,049,545 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 6,335,215 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 874,817 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 341,784 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion deriv | 2018-01-29 | 2018-01-29 | 2,475,118 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 324,306 | — | $0 | 359,992 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 2,348,550 | — | $0 | 2,606,982 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 126,703 | — | $0 | 486,695 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | C Conversion | 2018-01-29 | 2018-01-29 | 917,559 | — | $0 | 3,524,541 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | P Buy | 2018-01-25 | 2018-01-29 | 258,432 | $17.00 | $4.39M | 258,432 | SEC↗ |
| MNLO Menlo Therapeutics, Inc. | P Buy | 2018-01-25 | 2018-01-29 | 35,686 | $17.00 | $606.7K | 35,686 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-09-27 | 2017-09-29 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | C Conversion deriv | 2017-05-09 | 2017-05-09 | 1,506,818 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | P Buy | 2017-05-09 | 2017-05-09 | 470,000 | $17.00 | $7.99M | 1,976,818 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | C Conversion | 2017-05-09 | 2017-05-09 | 1,506,818 | — | $0 | 1,506,818 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-03-23 | 2017-03-27 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-06-29 | 2016-07-01 | 6,632 | — | $0 | 6,632 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 1,818,182 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 8,652,500 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 1,375,405 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 3,433,646 | — | $0 | 3,736,852 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-13 | 2015-10-13 | 454,545 | $11.00 | $5.00M | 4,191,397 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-07 | 2015-10-09 | 13,352 | $11.00 | $146.9K | 303,206 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion deriv | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 0 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion deriv | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 0 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | J Other | 2015-07-21 | 2015-07-21 | 106,647 | $5.22 | $556.7K | 2,215,946 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | J Other | 2015-07-21 | 2015-07-21 | 2,324 | $5.22 | $12.1K | 2,218,270 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | P Buy | 2015-07-21 | 2015-07-21 | 215,307 | $17.00 | $3.66M | 2,433,577 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | P Buy | 2015-07-21 | 2015-07-21 | 4,693 | $17.00 | $79.8K | 2,438,270 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 2,109,299 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 2,064,308 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 2,842 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 304,438 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 387,960 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 2,476,452 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 18,142 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-14 | 2,230 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-27 | 387,960 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-27 | 304,438 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-27 | 2,842 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-27 | 2,476,452 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-27 | 2,230 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion deriv | 2015-04-14 | 2015-04-27 | 18,140 | — | $0 | 0 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 2,230 | — | $0 | 3,192,064 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 304,438 | — | $0 | 3,189,834 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 2,842 | — | $0 | 2,885,396 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 387,960 | — | $0 | 2,882,554 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-14 | 1,005,136 | $5.00 | $5.03M | 4,197,200 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-14 | 7,364 | $5.00 | $36.8K | 4,204,564 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 18,142 | — | $0 | 2,494,594 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-14 | 2,476,452 | — | $0 | 2,476,452 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-27 | 304,438 | — | $0 | 3,189,832 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-27 | 2,842 | — | $0 | 2,885,394 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-27 | 387,960 | — | $0 | 2,882,552 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-27 | 18,140 | — | $0 | 2,494,592 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-27 | 2,230 | — | $0 | 3,192,062 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-27 | 1,005,136 | $5.00 | $5.03M | 4,197,198 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | P Buy | 2015-04-14 | 2015-04-27 | 7,364 | $5.00 | $36.8K | 4,204,562 | SEC↗ |
| CBYL Carbylan Therapeutics, Inc | C Conversion | 2015-04-14 | 2015-04-27 | 2,476,452 | — | $0 | 2,476,452 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 348,800 | — | $0 | 348,800 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 4,093 | — | $0 | 352,893 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 6,870 | — | $0 | 945,200 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 6,870 | — | $0 | 945,200 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 585,437 | — | $0 | 938,330 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 585,437 | — | $0 | 938,330 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 4,093 | — | $0 | 352,893 | SEC↗ |
| CAPN Capnia, Inc. | P Buy deriv | 2014-11-18 | 2014-11-20 | 348,800 | — | $0 | 348,800 | SEC↗ |
| CAPN Capnia, Inc. | J Other deriv | 2014-11-18 | 2014-11-20 | 17 | — | $0 | 331,111 | SEC↗ |
| CAPN Capnia, Inc. | J Other deriv | 2014-11-18 | 2014-11-20 | 1,002 | — | $0 | 331,094 | SEC↗ |
| CAPN Capnia, Inc. | J Other deriv | 2014-11-18 | 2014-11-20 | 4,205 | — | $0 | 330,092 | SEC↗ |
| CAPN Capnia, Inc. | J Other deriv | 2014-11-18 | 2014-11-20 | 3,778 | — | $0 | 325,887 | SEC↗ |
| CAPN Capnia, Inc. | J Other deriv | 2014-11-18 | 2014-11-20 | 322,109 | — | $0 | 322,109 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 31,250 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 1,755 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 95,112 | — | $0 | 1,755 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 19,766 | — | $0 | 96,867 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 1,102 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 59,638 | — | $0 | 1,102 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 178,408 | — | $0 | 64,740 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 240 | — | $0 | 239,148 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion deriv | 2014-11-18 | 2014-11-20 | 137,277 | — | $0 | 239,388 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 59,638 | — | $0 | 408,692 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 178,408 | — | $0 | 349,054 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 1,102 | — | $0 | 409,794 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 19,766 | — | $0 | 429,560 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 95,112 | — | $0 | 524,672 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 1,755 | — | $0 | 526,427 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 31,250 | — | $0 | 557,677 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 1,936,843 | — | $0 | 2,494,520 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 22,729 | — | $0 | 2,517,249 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 28,028 | — | $0 | 2,545,277 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 6,689 | — | $0 | 2,551,966 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 122 | — | $0 | 2,552,088 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 348,800 | — | $0 | 2,900,888 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 4,093 | — | $0 | 2,904,981 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 585,437 | — | $0 | 3,490,418 | SEC↗ |
| CAPN Capnia, Inc. | P Buy | 2014-11-18 | 2014-11-20 | 6,870 | — | $0 | 3,497,288 | SEC↗ |
| CAPN Capnia, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 9,427,595 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 110,642 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 136,441 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 32,569 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 596 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 1,567,879 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 18,401 | — | $0 | 0 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 137,277 | — | $0 | 169,035 | SEC↗ |
| CAPN Capnia, Inc. | C Conversion | 2014-11-18 | 2014-11-20 | 1,611 | — | $0 | 170,646 | SEC↗ |